Skip to content

A randomised controlled trial of larval therapy versus standard care in the management of necrotic wounds with and without methicillin-resistant Staphylococcus aureus (MRSA)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN03572121
Enrollment
Unknown
Registered
2004-09-30
Start date
2002-10-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Necrotic wounds with or without methicillin-resistant Staphylococcus aureus Injury, Occupational Diseases, Poisoning Necrotic wounds with or without methicillin-resistant Staphylococcus aureus

Interventions

Randomised controlled trial of larval therapy versus standard care

Sponsors

Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients over 18 years with necrotic wounds, in hospital or the community

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Efficacy of treatment

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026